These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 30044050
1. Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies. Metze C, Winkelmann A, Loebermann M, Hecker M, Schweiger B, Reisinger EC, Zettl UK. CNS Neurosci Ther; 2019 Feb; 25(2):245-254. PubMed ID: 30044050 [Abstract] [Full Text] [Related]
2. Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. Olberg HK, Eide GE, Cox RJ, Jul-Larsen Å, Lartey SL, Vedeler CA, Myhr KM. Eur J Neurol; 2018 Mar; 25(3):527-534. PubMed ID: 29205701 [Abstract] [Full Text] [Related]
3. Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study. Launay O, Abitbol V, Krivine A, Slama LB, Bourreille A, Dupas JL, Hébuterne X, Savoye G, Deplanque D, Bouhnik Y, Pelletier AL, Galtier F, Laharie D, Nachury M, Zerbib F, Allez M, Bommelaer G, Duclos B, Lucht F, Gougeon ML, Tartour E, Rozenberg F, Hanslik T, Beaugerie L, Carrat F, MICIVAX Study Group. J Crohns Colitis; 2015 Dec; 9(12):1096-107. PubMed ID: 26351392 [Abstract] [Full Text] [Related]
4. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [Abstract] [Full Text] [Related]
5. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949 [Abstract] [Full Text] [Related]
6. Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy. Ottóffy G, Horváth P, Muth L, Sólyom A, Garami M, Kovács G, Nyári T, Molnár D, Pauler G, Jankovics I. Pediatr Blood Cancer; 2014 Jun; 61(6):1013-6. PubMed ID: 24395342 [Abstract] [Full Text] [Related]
7. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age. Gorse GJ, Falsey AR, Fling JA, Poling TL, Strout CB, Tsang PH. Vaccine; 2013 May 01; 31(19):2358-65. PubMed ID: 23499604 [Abstract] [Full Text] [Related]
8. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure. Narang V, Lu Y, Tan C, Camous XFN, Nyunt SZ, Carre C, Mok EWH, Wong G, Maurer-Stroh S, Abel B, Burdin N, Poidinger M, Tambyah PA, Bosco N, Visan L, Ng TP, Larbi A. Front Immunol; 2018 May 01; 9():2465. PubMed ID: 30405641 [Abstract] [Full Text] [Related]
9. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease. Hagihara Y, Ohfuji S, Watanabe K, Yamagami H, Fukushima W, Maeda K, Kamata N, Sogawa M, Shiba M, Tanigawa T, Tominaga K, Watanabe T, Fujiwara Y, Hirota Y, Arakawa T. J Crohns Colitis; 2014 Mar 01; 8(3):223-33. PubMed ID: 24011513 [Abstract] [Full Text] [Related]
10. Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis. Bar-Or A, Freedman MS, Kremenchutzky M, Menguy-Vacheron F, Bauer D, Jodl S, Truffinet P, Benamor M, Chambers S, O'Connor PW. Neurology; 2013 Aug 06; 81(6):552-8. PubMed ID: 23851964 [Abstract] [Full Text] [Related]
11. The priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort study. Kang EK, Eun BW, Kim NH, Lim JS, Lee JA, Kim DH. BMC Infect Dis; 2016 Aug 22; 16(1):438. PubMed ID: 27549626 [Abstract] [Full Text] [Related]
15. Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study. Olberg HK, Cox RJ, Nostbakken JK, Aarseth JH, Vedeler CA, Myhr KM. Mult Scler; 2014 Jul 22; 20(8):1074-80. PubMed ID: 24436455 [Abstract] [Full Text] [Related]
16. Kinetics of the antibody response to seasonal influenza vaccination among the elderly. Kositanont U, Assantachai P, Wasi C, Puthavathana P, Praditsuwan R. Viral Immunol; 2012 Dec 22; 25(6):471-6. PubMed ID: 23061793 [Abstract] [Full Text] [Related]
18. Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine. Seo YB, Lee J, Song JY, Choi HJ, Cheong HJ, Kim WJ. Hum Vaccin Immunother; 2016 Dec 22; 12(2):478-84. PubMed ID: 26431466 [Abstract] [Full Text] [Related]
19. Evaluation of Waning Immunity at 6 Months after Both Trivalent and Quadrivalent Influenza Vaccination in Korean Children Aged 6-35 Months. Lee JH, Cho HK, Kim KH, Lee J, Kim YJ, Eun BW, Kim NH, Kim DH, Jo DS, Kim HM, Kim YK. J Korean Med Sci; 2019 Dec 02; 34(46):e279. PubMed ID: 31779056 [Abstract] [Full Text] [Related]
20. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan. Tsurudome Y, Kimachi K, Okada Y, Matsuura K, Ooyama Y, Ibaragi K, Kino Y, Ueda K. Microbiol Immunol; 2015 Oct 02; 59(10):597-604. PubMed ID: 26272602 [Abstract] [Full Text] [Related] Page: [Next] [New Search]